Episode 4: Delivering Possible
The pandemic began creating severe travel restrictions last March, but Kite's logistics team worked hard to continue helping people with cancer.
Note: The video depicts a period during COVID-19 before Kite’s Amsterdam facility was approved, allowing for end-to-end manufacturing in Europe. For patients in the U.S. receiving Kite’s CAR T-cell therapies, the manufacturing process occurs entirely within the U.S.
Read more: http://bit.ly/3vCGNbR
Watch Episode 3: https://bit.ly/3krrSvY